Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

Value assessment of deprescribing interventions: suggestions for improvement.

Hung A, Wang J, Moriarty F, et al. Value assessment of deprescribing interventions: suggestions for improvement. J Am Geriatr Soc. 2023;71(6):2023-2027. doi:10.1111/jgs.18298.

Save
Print
August 16, 2023
Hung A, Wang J, Moriarty F, et al. J Am Geriatr Soc. 2023;71(6):2023-2027.
View more articles from the same authors.

Deprescribing is used to reduce the risk of adverse drug events resulting from polypharmacy among older adults. This article outlines several recommendations for improved cost-effectiveness analyses of deprescribing interventions to support decision makers.

Save
Print
Cite
Citation

Hung A, Wang J, Moriarty F, et al. Value assessment of deprescribing interventions: suggestions for improvement. J Am Geriatr Soc. 2023;71(6):2023-2027. doi:10.1111/jgs.18298.